2022 White Paper on Recent Issues in Bioanalysis: Fda Draft Guidance on Immunogenicity Information in Prescription Drug Labeling, Lnp & Viral Vectors Therapeutics/Vaccines Immunogenicity, Prolongation Effect, Ada Affinity, Risk-Based Approaches, Ngs, Qpcr, Ddpcr Assays ( <u>Part 3</u> – Recommendations on Gene Therapy, Cell Therapy, Vaccines Immunogenicity & Technologies; Immunogenicity & Risk Assessment of Biotherapeutics and Novel Modalities; NAb Assays Integrated Approach)Luying Pan, Swati Gupta, Shirley Hopper et al.|Bioanalysis|2023Cited by 15
CRISPR/Cas9 Gene-Edited Hematopoietic Stem Cell Therapy for Sickle Cell DiseaseVionnie W.C. Yu, Susan C. Stevenson, Yi Liu et al.|Blood|2017Cited by 6